share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Jan 3 05:05

Gainers

  • Carmell (NASDAQ:CTCX) shares moved upwards by 228.8% to $0.92 during Thursday's pre-market session. The market value of their outstanding shares is at $19.1 million.
  • Revelation Biosciences (NASDAQ:REVB) shares moved upwards by 136.44% to $1.09. The company's market cap stands at $9.1 million.
  • Curis (NASDAQ:CRIS) stock rose 26.79% to $3.88. The company's market cap stands at $32.8 million.
  • MBX Biosciences (NASDAQ:MBX) shares increased by 25.5% to $23.13. The company's market cap stands at $772.9 million.
  • Know Labs (AMEX:KNW) stock rose 23.59% to $0.21. The market value of their outstanding shares is at $23.2 million.
  • Passage Bio (NASDAQ:PASG) shares moved upwards by 18.49% to $0.67. The market value of their outstanding shares is at $41.5 million.

Losers

  • Neumora Therapeutics (NASDAQ:NMRA) shares decreased by 82.1% to $1.9 during Thursday's pre-market session. The company's market cap stands at $306.9 million.
  • Baird Medical Investment (NASDAQ:BDMD) shares decreased by 43.43% to $4.3. The company's market cap stands at $153.8 million.
  • Vincerx Pharma (NASDAQ:VINC) stock declined by 12.49% to $0.23. The company's market cap stands at $8.3 million.
  • Cibus (NASDAQ:CBUS) shares decreased by 11.88% to $2.45. The market value of their outstanding shares is at $64.8 million.
  • CalciMedica (NASDAQ:CALC) shares decreased by 11.3% to $3.14. The market value of their outstanding shares is at $42.3 million.
  • Aethlon Medical (NASDAQ:AEMD) stock declined by 10.46% to $0.77. The market value of their outstanding shares is at $10.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment